LEADER 01495nam  2200481   450 
001 9910467599903321
005 20200520144314.0
010   $a1-78084-463-8
035   $a(CKB)4230000000000008
035   $a(MiAaPQ)EBC5092359
035   $a(Au-PeEL)EBL5092359
035   $a(CaPaEBR)ebr11451901
035   $a(OCoLC)1006403222
035   $a(EXLCZ)994230000000000008
100   $a20171107h20142014  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aCYP2D $egenetics, pharmacology and clinical relevance /$feditor, Pierre Baumann
210  1$aLondon, England :$cFuture Medicine Ltd,$d2014.
210  4$dİ2014
215   $a1 online resource (153 pages) $ccolor illustrations, tables
311   $a1-78084-464-6 
311   $a1-78084-462-X 
320   $aIncludes bibliographical references at the end of each chapters and index.
606   $aCytochrome P-450$xPhysiological effect
606   $aCytochrome P-450$xGenetics
606   $aCytochrome P-450$xTherapeutic use
608   $aElectronic books.
615  0$aCytochrome P-450$xPhysiological effect.
615  0$aCytochrome P-450$xGenetics.
615  0$aCytochrome P-450$xTherapeutic use.
676   $a574.1925
702   $aBaumann$b Pierre
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910467599903321
996   $aCYP2D$92154725
997   $aUNINA